Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Neuropathol Appl Neurobiol ; 31(4): 429-38, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16008827

RESUMEN

In the developing brain, neuronal differentiation is associated with permanent exit from the mitotic cycle. This raises the possibility that neuronal differentiation may suppress proliferative activity, even in neoplastic cells. As a first step towards understanding the relation between neuronal differentiation and mitotic cycling in brain tumours, we studied the expression of NeuN (a neuronal marker) and Ki-67 (a mitotic marker) by double-labelling immuno-fluorescence in 16 brain tumours with neuronal differentiation. The tumours included a series of 11 central neurocytomas, and five single cases of other tumour types. In the central neurocytomas, NeuN(+) cells had a 15-fold lower Ki-67 labelling index, on average, than did NeuN(-) cells (P < 0.01). In the other tumours (one extraventricular neurocytoma, one desmoplastic medulloblastoma, one olfactory neuroblastoma, one ganglioglioma and one anaplastic ganglioglioma), the Ki-67 labelling index was always at least fourfold lower in NeuN(+) cells than in NeuN(-) cells. These results indicate that neuronal differentiation is associated with a substantial decrease of proliferative activity in neoplastic cells of central neurocytomas, and suggest that the same may be true across diverse types of brain tumours. However, tumours with extensive neuronal differentiation may nevertheless have a high overall Ki-67 labelling index, if the mitotic activity of NeuN(-) cells is high. The correlation between NeuN expression and reduced mitotic activity in neurocytoma cells is consistent with the hypothesis that neuronal differentiation suppresses proliferation, but further studies will be necessary to determine causality and investigate underlying mechanisms.


Asunto(s)
Neoplasias Encefálicas/metabolismo , Índice Mitótico , Proteínas del Tejido Nervioso/biosíntesis , Neurocitoma/metabolismo , Neuronas/citología , Adolescente , Adulto , Diferenciación Celular/fisiología , Niño , Preescolar , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Procesamiento de Imagen Asistido por Computador , Antígeno Ki-67/metabolismo , Masculino , Microscopía Confocal , Persona de Mediana Edad , Neuronas/metabolismo
4.
J Ultrasound Med ; 20(11): 1233-40, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11758029

RESUMEN

OBJECTIVE: We encountered 3 organizing tentorial hematomas simulating posterior fossa lesions such as Dandy-Walker, dermoid, or arachnoid cysts. We sought to correlate the clinical and pathologic features that allow distinction of developmental cysts from hematomas in the posterior fossa on imaging. METHODS. Prenatal sonograms in all fetuses and fetal magnetic resonance scans in 2 of the 3 were reviewed. One case proceeding to term had serial imaging up to age 11 months. Two cases had complete neuropathologic evaluation after termination. Maternal records were reviewed. RESULTS: In each case, the ultrasonographic findings were reminiscent of a developmental cyst but with echogenic debris, a rim, or both. Magnetic resonance imaging suggested tentorial hemorrhage in 2, 1 also with falcine hemorrhage. Serial prenatal and postnatal imaging showed resolution in the surviving case. Pathologically, 2 fetuses had organizing tentorial hematomas causing brain displacement. Calcifications, white matter damage, germinal matrix hemorrhage, and brain stem necrosis were also present. One mother had von Willebrand disease. CONCLUSIONS: Tentorial hematomas, with or without maternal coagulopathy, should be considered in the prenatal ultrasonographic diagnosis of cystlike posterior fossa abnormalities containing echogenic material. Fetal magnetic resonance imaging can suggest blood products. Hypoxic-ischemic brain damage may be concurrent; however, resolution of the hematoma, with no apparent neurologic sequelae, can occur.


Asunto(s)
Quistes Aracnoideos/diagnóstico por imagen , Neoplasias Encefálicas/diagnóstico por imagen , Síndrome de Dandy-Walker/diagnóstico por imagen , Quiste Dermoide/diagnóstico por imagen , Enfermedades Fetales/diagnóstico por imagen , Hematoma Subdural/diagnóstico por imagen , Adulto , Fosa Craneal Posterior , Diagnóstico Diferencial , Femenino , Enfermedades Fetales/diagnóstico , Hematoma Subdural/diagnóstico , Humanos , Recién Nacido , Imagen por Resonancia Magnética , Edad Materna , Embarazo , Embarazo de Alto Riesgo , Ultrasonografía
6.
Acta Neurochir (Wien) ; 142(8): 871-8, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11086825

RESUMEN

OBJECTIVE: Parathyroid hormone-related protein (PTHrP) and its mRNA have been found to be expressed in a variety of human tumors including breast, prostate, colon, lung, renal and ovarian cancers. The purpose of this study is to evaluate the expression of PTH/PTHrP receptor and ligand in human glial tumors. METHODS: We examined the coexpression of PTH/PTHrP receptor and ligand in 73 glial tumors of different histological grades and 4 nonneoplastic human brain specimens and three glioblastoma cell lines, by using Western Blot analysis and immunohistochemical analysis. RESULTS: PTHrP and PTH/PTHrP receptors were shown in the neurons, reactive astrocytes and the endothelial cells of normal brain tissue as well as tumor cells, reactive astrocytes and vasculature of nonneoplastic tissue. They were expressed at higher levels in pure astrocytic tumors as compared to tumors with oligodendroglial components. CONCLUSION: PTH/PTHrP receptor and PTHrP ligand are co-expressed in human glial tumors. There increased expression suggests an autocrine and/or paracrine loop may exist.


Asunto(s)
Neoplasias Encefálicas/química , Glioma/química , Proteínas/análisis , Receptores de Hormona Paratiroidea/análisis , Adulto , Anciano , Western Blotting , Neoplasias Encefálicas/patología , Femenino , Regulación Neoplásica de la Expresión Génica , Glioblastoma/química , Glioma/patología , Humanos , Inmunohistoquímica , Ligandos , Masculino , Persona de Mediana Edad , Proteínas de Neoplasias/análisis , Hormona Paratiroidea/análisis , Proteína Relacionada con la Hormona Paratiroidea , Proteínas/genética , Receptores de Hormona Paratiroidea/genética , Células Tumorales Cultivadas
7.
J Rheumatol ; 27(4): 949-52, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10782821

RESUMEN

OBJECTIVE: It is not well appreciated that the clinical presentation of amyloid myopathy can mimic that of polymyositis. By retrospective clinicopathologic analysis we determined distinctive features of amyloid myopathy that differentiate the 2 diseases. METHODS: Two patients with clinical and histologic evidence of an inflammatory myopathy had fatal outcomes despite appropriate treatment for polymyositis. Their clinical course and original pathologic specimens were reviewed. In addition, original tissue samples were obtained and analyzed using Congo red staining and immunoperoxidase. RESULTS: The initial diagnosis of polymyositis was supported in both cases by muscle biopsies showing inflammatory infiltrates and elevations of creatine phosphokinase and by classic electromyography. Retrospective evaluation of the initial muscle biopsies disclosed subtle but incontrovertible evidence of vascular amyloid. Further analysis of the original specimens confirmed the presence of immunoglobin light chain (AL) amyloid. CONCLUSION: Amyloid myopathy can mimic polymyositis. Both can have similar clinical symptoms, as well as inflammatory infiltrates on muscle biopsy. Failure to recognize amyloid myopathy deprives patients of potentially life prolonging treatment. Congo red staining and immunohistochemical analysis of tissue could prevent misdiagnosis.


Asunto(s)
Amiloidosis/patología , Polimiositis/patología , Anciano , Biopsia , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad , Mieloma Múltiple/patología , Músculo Esquelético/patología , Miofibrillas/patología
8.
J Neuropathol Exp Neurol ; 59(12): 1044-50, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11138924

RESUMEN

Glioblastomas only rarely metastasize to sites outside the central nervous system, for reasons that are poorly understood. We report the clinicopathological and molecular genetic findings in 6 patients with metastatic glioblastoma. Four patients were under the age of 32 and all but 1 patient died within 2 yr of diagnosis. The number of metastases ranged from 1 to 3. At the time of death, 3 patients had apparent tumor control at their primary site. We evaluated DNA from both primary and metastatic glioblastomas for genetic alterations commonly found in glioblastomas: TP53 mutations, CDKN2A/p16 deletions, EGFR amplification, and allelic loss of chromosomes 1p, 10q and 19q. Four of 6 cases had TP53 mutations and only single cases had EGFR amplification, CDKN2A/p16 deletions, or allelic loss of 1p, 10q and 19q; 2 cases had no detectable genetic alterations. In 2 cases, the primary and metastatic tumors had identical genotypes. Remarkably, however, 2 cases had different TP53 alterations in the primary and metastatic lesions, or among the metastatic tumors, which suggests that some metastatic deposits may represent emergence of subclones that were not necessarily dominant in the primary tumor. The present observations and a review of the recent literature demonstrate that metastatic glioblastomas tend to occur in younger adults who do not follow long clinical courses, and may be characterized by TP53 mutations and differential clonal selection.


Asunto(s)
Glioblastoma/patología , Glioblastoma/secundario , Adulto , ADN de Neoplasias/genética , Resultado Fatal , Genes erbB-1/genética , Genes p16/genética , Genes p53/genética , Glioblastoma/genética , Glioblastoma/metabolismo , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Mutación/genética
9.
J Neurooncol ; 50(1-2): 165-72, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11245275

RESUMEN

Quantitative determination of the degree of vascularity has been shown to be independently prognostically significant in many human tumor types. In particular, tumor vascularity has known importance in astrocytomas, in which endothelial proliferation is a criterion for anaplasia in many grading schemes. This review analyzes reports of microvessel quantification performed on histologic sections of human brain tumors, and in which correlations with clinical outcome, or other pathobiologic factors have been made. Among the conclusions are: (1) brain tumors have the unique feature of complex 'glomeruloid' vessels, as well as heterogeneity of microvascular distribution and caliber; (2) lower-grade astrocytomas may incorporate pre-existing vessels, while glioblastomas may develop new vessels; (3) quantification may have additional independent prognostic value over and above routine histologic grade in low-grade astrocytomas with low tumor cell proliferative indices. These findings have implications for the appropriateness of antiangiogenic therapies.


Asunto(s)
Neoplasias Encefálicas/irrigación sanguínea , Neovascularización Patológica/patología , Vasos Sanguíneos/patología , Neoplasias Encefálicas/mortalidad , Neoplasias Encefálicas/patología , Capilares/patología , Femenino , Glioma/irrigación sanguínea , Glioma/mortalidad , Glioma/patología , Hemangioblastoma/irrigación sanguínea , Hemangioblastoma/mortalidad , Hemangioblastoma/patología , Humanos , Masculino , Meduloblastoma/irrigación sanguínea , Meduloblastoma/mortalidad , Meduloblastoma/patología , Microcirculación , Metástasis de la Neoplasia , Neoplasias/irrigación sanguínea , Neoplasias/patología , Pronóstico
10.
Pediatr Dev Pathol ; 3(1): 73-86, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10594135

RESUMEN

Inborn metabolic errors causing lysosomal storage, such as beta-galactosidase deficiency (G(M1) gangliosidosis [G(M1)]), have well-recognized effects on cellular function and morphology. In some classically "neuronal" storage diseases, including G(M1), neuroradiologic observations of infants have suggested a delay in myelination on the basis of persistently "immature" signal intensities monitored over time. We sought to evaluate in a semiquantitative fashion the pattern and degree of myelination in two infantile G(M1) patients, one boy and one girl, autopsied at 15 months of age. We assigned myelination degrees for defined sites on an ordinal scale of 0 to 4, and compared them to published population-based values for autopsied infants. In both patients, earlier-myelinating structures were comparable in development to that expected for postconceptional age, whereas later-myelinating structures were delayed. These data correlate well with the neuroradiologic diagnosis of myelination delay in these infants and suggest that the metabolic defect has a primary influence on myelin development, in addition to effects related to neuronal storage. Furthermore, our analysis by light and electron microscopy and lectin histochemistry of both CNS and systemic tissues, several of which had not been described, add to the understanding of the stored material in different cell types.


Asunto(s)
Gangliosidosis GM1/patología , Autopsia , Sistema Nervioso Central/patología , Resultado Fatal , Femenino , Humanos , Lactante , Masculino , Vaina de Mielina/patología
11.
J Neuropathol Exp Neurol ; 58(9): 887-902, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10499433

RESUMEN

Inborn metabolic errors causing lysosomal storage have well-recognized effects on neuronal function and morphology. In some classically "neuronal" storage diseases, however, neuroradiologic observations of infants have suggested a delay in central nervous system myelination based on persistently "immature" signal intensities monitored over time. This review summarizes reported neuropathologic evaluations of central white matter in infantile and juvenile patients and in corresponding animal models with lysosomal storage disorders. The observed neuropathology is examined in light of published studies of the biochemistry and microscopic anatomy of normal myelinogenesis. Finally, arguments are advanced that at least part of the deficiency of white matter is attributable to direct effects of the metabolic state on oligodendrocyte maturation and function, in addition to secondary effects on neurons and their axons.


Asunto(s)
Encéfalo/crecimiento & desarrollo , Enfermedades por Almacenamiento Lisosomal/fisiopatología , Animales , Senescencia Celular/fisiología , Modelos Animales de Enfermedad , Humanos , Vaina de Mielina/fisiología , Oligodendroglía/fisiología
12.
Acta Neurochir (Wien) ; 141(3): 307-13, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10214488

RESUMEN

The clinical, radiologic and pathologic features of a case of parasagittal solitary fibrous tumor of the meninges are reported. The patient was a 44 year-old male who presented with a complex partial seizure and a history of headaches and confusion. Radiological studies showed a large extra-axial dural-based mass in the right parietal region, predominantly isointense with gray matter and hypointense with respect to white matter on T1-weighted images, and hypointense with respect to gray matter on T2-weighted images. At surgery, the mass was very vascular, quite firm and very adherent to the convexity. Histologically the tumor was composed of spindle-shaped cells growing in fascicles within a collagenous matrix. Solitary fibrous tumor of the meninges is a newly described entity, which should be kept in mind in the clinical and radiological differential diagnosis of extra-axial brain tumors.


Asunto(s)
Neoplasias Meníngeas/patología , Neoplasias de Tejido Fibroso/patología , Lóbulo Parietal/patología , Adulto , Antígenos CD34/análisis , Antígenos de Neoplasias/análisis , Biomarcadores de Tumor/análisis , Diagnóstico Diferencial , Humanos , Masculino , Neoplasias Meníngeas/inmunología , Meningioma/inmunología , Meningioma/patología , Neoplasias de Tejido Fibroso/inmunología , Pronóstico
13.
Mod Pathol ; 12(12): 1186-91, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10619274

RESUMEN

Myeloblastomas (granulocytic sarcomas) occurring within the central nervous system (CNS) are extremely rare lesions that may develop in patients with acute or chronic myeloproliferative disorders. The majority of such lesions involve brain or spinal cord by contiguous spread from meningeal or bony sites, rather than originating within the CNS parenchyma. We describe a patient with acute myelogenous leukemia in remission, who developed a purely intraparenchymal cerebellar myeloblastoma with megakaryocytic differentiation. The neoplastic cells expressed the megakaryocytic markers factor VIII-related antigen and platelet glycoprotein-IIIa (CD61), and showed ultrastructural features that were indicative of megakaryocytic differentiation. Clinically, myeloblastomas of the CNS invoke a broad differential diagnosis that includes abscess, hemorrhage, and metastatic neoplasms because of their intraparenchymal location and radiologic features. Although they are rare, myeloblastomas should be included in the histopathologic differential diagnosis of a poorly differentiated neoplasm occurring within the CNS, particularly in a patient with a history of myeloproliferative or myelodysplastic disease.


Asunto(s)
Neoplasias Cerebelosas/patología , Leucemia Megacarioblástica Aguda/patología , Leucemia Mieloide Aguda/patología , Leucemia Mieloide/patología , Antígenos CD/metabolismo , Diferenciación Celular , Neoplasias Cerebelosas/complicaciones , Neoplasias Cerebelosas/metabolismo , Diagnóstico Diferencial , Humanos , Integrina beta3 , Leucemia Megacarioblástica Aguda/complicaciones , Leucemia Megacarioblástica Aguda/metabolismo , Leucemia Mieloide/complicaciones , Leucemia Mieloide/metabolismo , Leucemia Mieloide Aguda/complicaciones , Leucemia Mieloide Aguda/metabolismo , Masculino , Persona de Mediana Edad , Síndromes Mielodisplásicos/complicaciones , Glicoproteínas de Membrana Plaquetaria/metabolismo , Recurrencia , Factor de von Willebrand/metabolismo
14.
J Neurosurg ; 89(1): 60-8, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9647173

RESUMEN

OBJECT: The study was conducted to determine the association between dual-isotope single-photon emission computerized tomography (SPECT) scanning and histopathological findings of tumor recurrence and survival in patients treated with high-dose radiotherapy for glioblastoma multiforme. METHODS: Studies in which SPECT with 201Tl and 99mTc-hexamethypropyleneamine oxime (HMPAO) were used were performed 1 day before reoperation in 47 patients with glioblastoma multiforme who had previously been treated by surgery and high-dose radiotherapy. Maximum uptake of 201Tl in the lesion was expressed as a ratio to that in the contralateral scalp, and uptake of 99mTc-HMPAO was expressed as a ratio to that in the cerebellar cortex. Patients were stratified into groups based on the maximum radioisotope uptake values in their tumor beds. The significance of differences in patient gender, histological characteristics of tissue at reoperation, and SPECT uptake group with respect to 1-year survival was elucidated by using the chi-square statistic. Comparisons of patient ages and time to tumor recurrence as functions of 1-year survival were made using the t-test. Survival data at 1 year were presented according to the Kaplan-Meier method, and the significance of potential differences was evaluated using the log-rank method. The effects of different variables (tumor type, time to recurrence, and SPECT grouping) on long-term survival were evaluated using Cox proportional models that controlled for age and gender. All patients in Group I (201Tl ratio < 2 and 99mTc-HMPAO ratio < 0.5) showed radiation changes in their biopsy specimens: they had an 83.3% 1-year survival rate. Group II patients (201Tl ratio < 2 and 99mTc-HMPAO ratio of > or = 0.5 or 201Tl ratio between 2 and 3.5 regardless of 99mTc-HMPAO ratio) had predominantly infiltrating tumor (66.6%); they had a 29.2% 1-year survival rate. Almost all of the patients in Group III (201Tl ratio > 3.5 and 99mTc-HMPAO ratio > or = 0.5) had solid tumor (88.2%) and they had a 6.7% 1-year survival rate. Histological data were associated with 1-year survival (p < 0.01): however, SPECT grouping was more closely associated with 1-year survival (p < 0.001) and was the only variable significantly associated with long-term survival (p < 0.005). CONCLUSIONS: Dual-isotope SPECT data correlate with histopathological findings made at reoperation and with survival in patients with malignant gliomas after surgical and high-dose radiation therapy.


Asunto(s)
Neoplasias Encefálicas/diagnóstico por imagen , Glioblastoma/diagnóstico por imagen , Tomografía Computarizada de Emisión de Fotón Único/métodos , Adolescente , Adulto , Factores de Edad , Anciano , Neoplasias Encefálicas/patología , Neoplasias Encefálicas/radioterapia , Neoplasias Encefálicas/cirugía , Cerebelo/diagnóstico por imagen , Distribución de Chi-Cuadrado , Femenino , Glioblastoma/patología , Glioblastoma/radioterapia , Glioblastoma/cirugía , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Recurrencia Local de Neoplasia/diagnóstico por imagen , Recurrencia Local de Neoplasia/patología , Modelos de Riesgos Proporcionales , Radiofármacos , Dosificación Radioterapéutica , Reoperación , Cuero Cabelludo/diagnóstico por imagen , Factores Sexuales , Tasa de Supervivencia , Exametazima de Tecnecio Tc 99m , Radioisótopos de Talio
15.
Am J Surg Pathol ; 22(6): 736-41, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9630181

RESUMEN

Inflammatory lesions of the hypophysis include lymphocytic hypophysitis, pituitary abscess, and granulomatous inflammation, with or without specific infections (i.e., sarcoidosis, mycobacteria). These lesions are known to mimic pituitary neoplasms. We report the clinical and pathologic findings in three patients who underwent transsphenoidal resection for presumed pituitary adenoma. Two were women aged 30 years (one with a 5-month history of headache, the other with a 1-year history of menstrual irregularity) and one was a 12-year-old girl with headache, nausea, and diabetes insipidus. Preoperative endocrinologic studies showed increased prolactin in one patient and normal serum thyroid stimulating hormone and prolactin levels in another. By magnetic resonance imaging (MRI), the first case had a 1.2-cm mass with increased signal on T1 and isointensity on T2, ring enhancement after gadolinium, and lateral deviation of the pituitary stalk. The second patient had a 1.1-cm "cystic" mass seen during magnetic resonance imaging with adjacent bony changes seen during computed tomography. In the third, computed tomography showed a hypodense pituitary mass that enlarged during 1-month observation. At surgery, abnormal soft tissue surrounded liquefied material in the anterior pituitary in all cases. Histologic studies showed fragments of intact normal anterior pituitary with preserved vascular and reticulin network and regions of anterior pituitary infiltrated by foamy histiocytes. Other fragments resembled granulation tissue, and some consisted of acellular debris. Histiocytes were immunoreactive for the macrophage marker CD68 and negative for S-100 and CD1a. Ultrastructurally, the normal adenohypophysis was permeated by lipid-laden macrophages. There were no well-formed granulomas or giant cells, hemosiderin, acid-fast bacilli, or fungi. Serial sections and keratin immunostains failed to identify an epithelial cyst lining or keratin among the debris. We propose the term "xanthomatous hypophysitis" for this lesion.


Asunto(s)
Enfermedades del Sistema Endocrino/diagnóstico , Enfermedades de la Hipófisis/diagnóstico , Neoplasias Hipofisarias/diagnóstico , Adulto , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Niño , Diagnóstico Diferencial , Enfermedades del Sistema Endocrino/metabolismo , Enfermedades del Sistema Endocrino/patología , Femenino , Humanos , Inmunohistoquímica , Imagen por Resonancia Magnética , Microscopía Electrónica , Enfermedades de la Hipófisis/metabolismo , Enfermedades de la Hipófisis/patología , Neoplasias Hipofisarias/metabolismo , Neoplasias Hipofisarias/patología , Neoplasias Hipofisarias/ultraestructura
17.
Arch Pathol Lab Med ; 121(11): 1199-206, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9372749

RESUMEN

OBJECTIVE: To assess the efficacy of 10% formalin perfusion fixation as a method of rapid fixation to examine the human brain immediately following autopsy. DESIGN: Compare the histology and immunohistochemistry from human brains in which one hemisphere undergoes perfusion fixation using 10% buffered formalin, and the contralateral nonperfused hemisphere undergoes standard 14-day immersion fixation in 8 L of 10% buffered formalin. SETTING: Autopsy material in a general medical-surgical university hospital. PARTICIPANTS: Pathologists, neuropathologists, resident pathologists, and pathology assistants. INTERVENTION: Immediately following brain removal, a single hemisphere was perfused with 1 L 10% buffered formalin over a 15- to 20-minute period. The contralateral nonperfused hemisphere served as a control, undergoing standard immersion fixation for 2 weeks in 10% formalin. The perfusion-fixation hemisphere was immediately available for neuropathologic examination, and histologic sections of the brain were processed immediately with the other necropsy tissue sections. This allows completion of a final autopsy neuropathology report within 3 to 5 days in concert with the systemic section of the report. MAIN OUTCOME MEASURE: Perfusion-fixation brain sections were compared with immersion-fixation brain sections from the same brain. The effects on hematoxylin-eosin, Bielschowsky's silver, and immunohistochemical staining were evaluated by an experienced neuropathologist and a general pathologist with no prior knowledge of the fixation technique. RESULTS: Perfusion fixation revealed equal and occasionally superior histologic sections compared with traditional immersion fixation in terms of (1) technical preparation of section, (2) quality and intensity of staining with both hematoxylin-eosin and silver, and (3) immunoreactivity localization with a variety of immunohistochemical reactions. CONCLUSIONS: Immediate perfusion of the brain is an easily performed fixation technique that yields comparable or superior fixation to prolonged immersion fixation and allows an immediate complete neuropathologic examination and report within 3 to 5 days of performance of the autopsy.


Asunto(s)
Encéfalo/patología , Perfusión/métodos , Fijación del Tejido/métodos , Anciano , Anciano de 80 o más Años , Tampones (Química) , Colorantes , Método Doble Ciego , Eosina Amarillenta-(YS) , Femenino , Colorantes Fluorescentes , Formaldehído , Hematoxilina , Humanos , Inmersión , Inmunohistoquímica , Masculino , Tinción con Nitrato de Plata , Coloración y Etiquetado
18.
Am J Pathol ; 151(2): 565-71, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9250169

RESUMEN

Gangliogliomas are rare tumors of the central nervous system that account for approximately 1% of all brain tumors. Histologically, gangliogliomas are composed of intimately admixed glial and neuronal components, the pathological origins of which remain to be characterized. Clonal analysis through examination of the pattern of the X chromosome inactivation allows one to distinguish monoclonal differentiation of a genetically abnormal progenitor cell from parallel, but independent, clonal expansion of two different cell types during tumorigenesis in biphasic neoplasms, such as gangliogliomas. In the present study, we investigated the clonality of eight gangliogliomas from female patients using both methylation- and transcription-based clonality assays at the androgen receptor locus (HUMARA) on the X chromosome. Among tumors from seven patients who were heterozygous at the HUMARA locus, five were identified as monoclonal with the methylation-based clonality assay, and the results were confirmed by the transcription-based method, whereas two were shown to be polyclonal by the methylation-based clonality assay but monoclonal by transcription-based clonality analysis. We conclude that the predominant cell types in most gangliogliomas are monoclonal in origin and derive from a common precursor cell that subsequently differentiates to form neoplastic glial and neuronal elements.


Asunto(s)
Neoplasias Encefálicas/genética , Ganglioglioma/genética , Neuroglía/patología , Neuronas/patología , Receptores Androgénicos/genética , Cromosoma X , Adulto , Neoplasias Encefálicas/patología , Niño , Células Clonales , ADN de Neoplasias/análisis , Femenino , Ganglioglioma/patología , Humanos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA